FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention relates to biotechnology, namely to obtaining infestin-4 mutants, and can be used for diagnostic purposes in the determination of characteristics of clotting of blood and its components. A polypeptide is characterised by a sequence of the infestin 4 mutant MutB SEQ ID NO: 1. The said sequence can have modifications outside inhibiting the loop part, which essentially preserve the activity of the said polypeptide. The polypeptide is used for the inhibition of contact activation in a tested sample of blood or its product in order to increase the time of the sample storage.
EFFECT: invention makes it possible to obtain the highly-selective inhibitor fXIIa, selectivity or activity of which is higher than in the native infestin-4 and Mut15.
25 cl, 7 dwg, 3 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
SCREENING-TEST OF DETERMINING COAGULATION CONTACT WAY (STOKPK) | 2017 |
|
RU2660706C1 |
FUSED PROTEIN OF THIOREDOXIN AND INFESTIN 4 DOMAIN, METHOD FOR PREPARING IT, EXPRESSION PLASMID DNA CODING FUSED PROTEIN, AND BACTERIUM Escherichia coli TRANSFORMED BY THIS PLASMID DNA | 2012 |
|
RU2528251C2 |
METHOD OF DETERMINING SPACE-TIME DISTRIBUTION OF PROTEOLYTIC ENZYME ACTIVITY IN HETEROGENEOUS SYSTEM, DEVICE FOR REALISING THEREOF AND METHOD OF DIAGNOSING HEMOSTASIS SYSTEM DISORDERS BY CHANGE OF SPACE-TIME DISTRIBUTION OF PROTEOLYTIC ENZYME ACTIVITY IN HETEROGENIC SYSTEM | 2011 |
|
RU2518247C2 |
MODIFIED DNA APTAMERS INHIBITING THROMBIN ACTIVITY | 2009 |
|
RU2410432C1 |
METHOD OF INHIBITING THROMBUS FORMATION AND ACCELERATION OF FIBRINOLYSIS WITH DNA APTAMERS INHIBITING ACTIVITY OF THROMBIN IN EXPERIMENT | 2014 |
|
RU2559545C1 |
DIRECT THROMBIN INHIBITOR, POSSESSING ANTIPROLIFERATIVE ACTION | 2007 |
|
RU2369615C2 |
NOVEL COMPOUNDS POSSESSING ANTICOAGULANT FUNCTION, BASED ON THEM PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF THROMBOTIC CONDITIONS AND PLASMA-SUBSTITUTING SOLUTION FOR CORRECTION OF HYPERCOAGULATION DISORDERS IN HEMODILUTION | 2007 |
|
RU2353619C2 |
APTAMER OLIGONUCLEOTIDE - DIRECT THROMBIN INHIBITOR | 2008 |
|
RU2401306C2 |
REAGENT KIT FOR DIAGNOSING DEGREE OF NEUROINFLAMMATION | 2018 |
|
RU2698206C1 |
METHOD FOR MEASURING THROMBIN ACTIVITY | 2010 |
|
RU2429488C1 |
Authors
Dates
2015-07-10—Published
2013-11-28—Filed